Cargando…

1497. Cryptococcal Antigen Screening and Pre-emptive Fluconazole Therapy in HIV-infected Patients: A Multicenter, Retrospective Study in China

BACKGROUND: The implementation and effectivention of CrAg screening programs and pre-emptive treatment remains unclear in China. METHODS: We performed a multicenter, retrospective study at eight hospitals from 1st Jan 2019 to 31st Dec 2020, to evaluate whether CrAg screening programs and preemptive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Yanqiu, Chen, Yaokai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677837/ http://dx.doi.org/10.1093/ofid/ofad500.1332

Ejemplares similares

Comparison of amphotericin B deoxycholate in combination with either flucytosine or fluconazole, and voriconazole plus flucytosine for the treatment of HIV-associated cryptococcal meningitis: a prospective multicenter study in China
por: Zhao, Ting, et al.
Publicado: (2022)

Prospective cohort of AIDS patients screened for cryptococcal antigenaemia, pre-emptively treated and followed in Brazil
por: Borges, Moara Alves Santa Bárbara, et al.
Publicado: (2019)

The prevalence of cryptococcal antigen (CrAg) and benefits of pre-emptive antifungal treatment among HIV-infected persons with CD4+ T-cell counts < 200 cells/μL: evidence based on a meta-analysis
por: Li, Yao, et al.
Publicado: (2020)

Correction to: The prevalence of cryptococcal antigen (CrAg) and benefits of pre-emptive antifungal treatment among HIV-infected persons with CD4+ T-cell counts < 200 cells/μL: evidence based on a meta-analysis
por: Li, Yao, et al.
Publicado: (2021)

Potential Predictors and Survival Analysis of the Relapse of HIV-Associated Cryptococcal Meningitis: A Retrospective Study
por: Li, Yao, et al.
Publicado: (2021)

1485. Landscape of peripheral blood mononuclear cell single-cell transcriptomes in HIV-infected patients with cryptococcal meningitis
por: Chen, Yaokai, et al.
Publicado: (2023)

High dose fluconazole in salvage therapy for HIV-uninfected cryptococcal meningitis
por: Zhao, Hua-Zhen, et al.
Publicado: (2018)

1497. Epidemiology of RSV infection in Japan: A nationwide claims database analysis
por: Kobayashi, Yasuhiro, et al.
Publicado: (2020)

1497. Evidence-Based Care for Sexually Transmitted Infections: Missed Opportunities in an Academic Medical Center
por: Filardo, Thomas, et al.
Publicado: (2018)

Emerging fluconazole resistance: Implications for the management of cryptococcal meningitis
por: Mpoza, Edward, et al.
Publicado: (2017)

88462 Fluconazole distribution in CNS and gynecological tissues in HIV-related cryptococcal meningitis decedents
por: Nicol, Melanie R., et al.
Publicado: (2021)

Reflexive Laboratory-Based Cryptococcal Antigen Screening and Preemptive Fluconazole Therapy for Cryptococcal Antigenemia in HIV-Infected Individuals With CD4 <100 Cells/µL: A Stepped-Wedge, Cluster-Randomized Trial
por: Meya, David B., et al.
Publicado: (2019)

Retrospective Study of Cryptococcal Meningitis With Elevated Minimum Inhibitory Concentration to Fluconazole in Immunocompromised Patients
por: Nasri, Hashem, et al.
Publicado: (2016)

Screening for Cryptococcal Antigenemia and Burden of Cryptococcosis at the Time of HIV Diagnosis: A Retrospective Multicenter Study
por: Huang, Sung-Hsi, et al.
Publicado: (2021)

Underlying Cryptococcal Diseases and the Correlation With Serum Cryptococcal Antigen Titers in Hospitalized HIV-Infected Patients Screened Positive for Cryptococcal Antigenemia
por: Xu, Miaomiao, et al.
Publicado: (2020)

1497. Relapsing Clostridium difficile Infection: Resolution with Combined Patient Choice Fecal Microbiota Transplantation, Vancomycin Taper, and Vancomycin Suppression
por: Shadowen, Rebecca D, et al.
Publicado: (2019)

Routine Cryptococcal Antigen Screening in Solid Organ Transplant Recipients: Is it Time to Save Lives and Money?
por: George, Ige, et al.
Publicado: (2017)

Cost Effectiveness of Cryptococcal Antigen Screening as a Strategy to Prevent HIV-Associated Cryptococcal Meningitis in South Africa
por: Jarvis, Joseph N., et al.
Publicado: (2013)

Su1497: EFFECT OF SARS COV-2 VACCINE IN IBD PATIENTS ON BIOLOGIC THERAPY INCLUDING LIVER TRANSPLANT RECIPIENTS.
por: Brezina, Jan, et al.
Publicado: (2022)

Population Pharmacokinetics and Cerebrospinal Fluid Penetration of Fluconazole in Adults with Cryptococcal Meningitis
por: Stott, Katharine E., et al.
Publicado: (2018)

Dynamic ploidy changes drive fluconazole resistance in human cryptococcal meningitis
por: Stone, Neil R.H., et al.
Publicado: (2019)

375. Cryptococcal Antigenemia in Advanced HIV Infection
por: Ahuja, Jatin, et al.
Publicado: (2019)

Safety and tolerability of nevirapine-based antiretroviral therapy in HIV-infected patients receiving fluconazole for cryptococcal prophylaxis: a retrospective cohort study
por: Manosuthi, Weerawat, et al.
Publicado: (2005)

Symptomatic Neuromas in Lower Extremity Amputees: Implications for Pre-emptive–targeted Muscle Reinnervation
por: Nigam, Manas, et al.
Publicado: (2019)

High Prevalence of Cryptococcal Antigenaemia and Disseminated Cryptococcal Disease Amongst Patients with Advanced HIV Disease in Pune, India
por: Kumar Medisetty, Mahender, et al.
Publicado: (2017)

1713. Impact of False-Positive Low-Titer Cryptococcal Antigen Testing
por: Bhatt, Mahesh, et al.
Publicado: (2019)

Effect of oral fluconazole 1200 mg/day on QT interval in African adults with HIV-associated cryptococcal meningitis
por: Molloy, Síle F., et al.
Publicado: (2018)

Fluconazole plus flucytosine is a good alternative therapy for non‐HIV and non‐transplant‐associated cryptococcal meningitis: A retrospective cohort study
por: Li, Zhanyi, et al.
Publicado: (2019)

Prevalence of Cryptococcal Antigenemia and Cost-Effectiveness of a Cryptococcal Antigen Screening Program – Vietnam
por: Smith, Rachel M., et al.
Publicado: (2013)

Evaluation of the initial 12 months of a routine cryptococcal antigen screening program in reduction of HIV-associated cryptococcal meningitis in Uganda
por: Enock, Kagimu, et al.
Publicado: (2022)

A Case of Cryptococcal Hepatitis in an HIV Patient with a Negative Serum Cryptococcal Antigen
por: Estifan, Elias, et al.
Publicado: (2019)

1583. Optimal timing of antiretroviral therapy initiation in AIDS-associated Toxoplasma encephalitis: a prospective observational multicenter study in China
por: Chen, yaokai, et al.
Publicado: (2023)

Regional blocks for pre-emptive anti-emesis
por: Gupta, Deepak
Publicado: (2012)

Pre-emptive genomic surveillance of emerging ebolaviruses
por: Postigo-Hidalgo, Ignacio, et al.
Publicado: (2020)

Adding pre-emptive anticholinergics to antipsychotics: Is it justified?
por: Chatterjee, Kaushik, et al.
Publicado: (2022)

253. Evaluation of a Cryptococcal Antigen Lateral Flow Assay and the Burden of Cryptococcal Disease: A Cohort Study at Grady Memorial Hospital in Atlanta, Georgia
por: Harrington, Kristin, et al.
Publicado: (2019)

1613. Frailty is Associated with Intestinal Barrier Dysfunction in Aging People Living with HIV
por: xu, xiaolei, et al.
Publicado: (2023)

Pre-Emptive and Non-Pre-Emptive Goal Programming Problems for Optimal Menu Planning in Diet Management of Indian Diabetes Mellitus Patients
por: Paidipati, Kiran Kumar, et al.
Publicado: (2021)

847. Cryptococcal disease in HIV and non-HIV-infected patients: clinical features and outcome
por: Roman-Montes, Carla M, et al.
Publicado: (2023)

397. Long-Term Mortality of HIV Patients Following Cryptococcal Infection
por: Hevey, Matthew, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gceocv90iule07e8aa4e7f7i28